Alefacept - a drug review.

Hadar Lev-Tov, Suhail Hadi

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Alefacept is an immunobiologic agent that has been recently introduced in the treatment of plaque psoriasis. The author presents a brief review of the drug, its efficacy and safety profile. Recent case reports of the use of alefacept in conjunction with other conditions as well as the drug's possible use for treatment of other conditions are reviewed as well.

Original languageEnglish (US)
Pages (from-to)163-164
Number of pages2
JournalReviews on Recent Clinical Trials
Volume1
Issue number2
DOIs
StatePublished - May 2006
Externally publishedYes

Fingerprint

Psoriasis
Pharmaceutical Preparations
Safety
alefacept

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology

Cite this

Alefacept - a drug review. / Lev-Tov, Hadar; Hadi, Suhail.

In: Reviews on Recent Clinical Trials, Vol. 1, No. 2, 05.2006, p. 163-164.

Research output: Contribution to journalArticle

Lev-Tov, Hadar ; Hadi, Suhail. / Alefacept - a drug review. In: Reviews on Recent Clinical Trials. 2006 ; Vol. 1, No. 2. pp. 163-164.
@article{6d2ab70fb6734e6ca3421201eb7c979d,
title = "Alefacept - a drug review.",
abstract = "Alefacept is an immunobiologic agent that has been recently introduced in the treatment of plaque psoriasis. The author presents a brief review of the drug, its efficacy and safety profile. Recent case reports of the use of alefacept in conjunction with other conditions as well as the drug's possible use for treatment of other conditions are reviewed as well.",
author = "Hadar Lev-Tov and Suhail Hadi",
year = "2006",
month = "5",
doi = "10.2174/157488706776876481",
language = "English (US)",
volume = "1",
pages = "163--164",
journal = "Reviews on Recent Clinical Trials",
issn = "1574-8871",
publisher = "Bentham Science Publishers B.V.",
number = "2",

}

TY - JOUR

T1 - Alefacept - a drug review.

AU - Lev-Tov, Hadar

AU - Hadi, Suhail

PY - 2006/5

Y1 - 2006/5

N2 - Alefacept is an immunobiologic agent that has been recently introduced in the treatment of plaque psoriasis. The author presents a brief review of the drug, its efficacy and safety profile. Recent case reports of the use of alefacept in conjunction with other conditions as well as the drug's possible use for treatment of other conditions are reviewed as well.

AB - Alefacept is an immunobiologic agent that has been recently introduced in the treatment of plaque psoriasis. The author presents a brief review of the drug, its efficacy and safety profile. Recent case reports of the use of alefacept in conjunction with other conditions as well as the drug's possible use for treatment of other conditions are reviewed as well.

UR - http://www.scopus.com/inward/record.url?scp=45549104350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45549104350&partnerID=8YFLogxK

U2 - 10.2174/157488706776876481

DO - 10.2174/157488706776876481

M3 - Article

C2 - 18473967

AN - SCOPUS:45549104350

VL - 1

SP - 163

EP - 164

JO - Reviews on Recent Clinical Trials

JF - Reviews on Recent Clinical Trials

SN - 1574-8871

IS - 2

ER -